Insider · CIK 0001701180

Danos Olivier

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001701180

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−5,452 sh	$8.07	−$44K	226,348
2025-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−12.6K sh	$7.73	−$97.6K	172,453
2025-01-02	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+59.3K sh	—	—	231,800
2025-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+95.7K sh	—	—	95,721
2024-08-01	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+58.9K sh	—	—	185,083
2024-06-28	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+1,363 sh	$9.95	+$13.6K	126,216
2024-01-02	RGNXREGENXBIO Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−8,410 sh	$17.95	−$151K	86,391
2024-01-02	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+38.5K sh	—	—	124,853
2024-01-02	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+61.1K sh	—	—	61,050
2023-06-30	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+1,123 sh	$16.99	+$19.1K	94,801
2023-01-03	RGNXREGENXBIO Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,058 sh	$22.68	−$46.7K	27,020
2023-01-03	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+65.9K sh	—	—	92,950
2023-01-03	RGNXREGENXBIO Inc. · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+53K sh	—	—	52,986
2022-06-30	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+728 sh	$21.00	+$15.3K	93,678
2022-01-03	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+10.7K sh	—	—	29,078
2022-01-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+51.1K sh	—	—	51,100
2022-01-01	RGNXREGENXBIO Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,221 sh	$32.70	−$39.9K	18,378
2021-12-31	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+1 sh	$27.80	+$27.795	19,599
2021-06-30	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+555 sh	$33.02	+$18.3K	19,598
2021-01-04	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+11.6K sh	—	—	19,043
2021-01-04	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+52.5K sh	—	—	52,500
2020-06-30	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+641 sh	$31.31	+$20.1K	7,443
2020-01-02	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+48K sh	—	—	48,000
2019-12-31	RGNXREGENXBIO Inc.A Award	Chief Scientific Officer	AAward	+302 sh	$34.82	+$10.5K	6,802
2019-04-15	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,000 sh	$20.35	+$40.7K	8,500
2019-04-15	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−1,000 sh	$52.23	−$52.2K	7,500
2019-04-15	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−1,000 sh	$53.09	−$53.1K	6,500
2019-04-15	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,000 sh	—	—	71,500
2019-03-12	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$20.35	+$102K	6,500
2019-03-12	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,000 sh	—	—	73,500
2019-01-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+48K sh	—	—	48,000
2018-11-30	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,500 sh	$20.35	+$30.5K	1,500
2018-11-30	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,500 sh	—	—	78,500
2018-10-08	RGNXREGENXBIO Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$20.35	+$407K	20,000
2018-10-08	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−3,500 sh	$62.79	−$220K	16,500
2018-10-08	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−12.3K sh	$63.73	−$783K	4,216
2018-10-08	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−4,000 sh	$64.78	−$259K	216
2018-10-08	RGNXREGENXBIO Inc.S Sale	Chief Scientific Officer	SSale	−216 sh	$65.60	−$14.2K	0
2018-10-08	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	80,000
2018-01-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+41.3K sh	—	—	41,250
2017-03-27	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Apr 44
Danos Olivier0001562180-25-003008
SEC(opens sec.gov)
Jan 64
Danos Olivier0001562180-25-000189
SEC(opens sec.gov)
Aug 54
Danos Olivier0001562180-24-006013
SEC(opens sec.gov)
Jan 44
Danos Olivier0001562180-24-000249
SEC(opens sec.gov)
Jan 54
Danos Olivier0001562180-23-000220
SEC(opens sec.gov)
Jan 44
Danos Olivier0001562180-22-000156
SEC(opens sec.gov)
Jan 64
Danos Olivier0001562180-21-000141
SEC(opens sec.gov)

Companies

REGENXBIO Inc.Chief Scientific OfficerRGNX

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850